Pfizer warns of slowdown in 2005
October 27, 2004Pfizer has warned that growth in 2005 could be held back by generic competition and other increasing market pressures.The company's …
Prexige launch delayed
October 27, 2004Novartis has delayed the launch of its potential blockbuster painkiller Prexige until 2007, in the wake of Vioxx's withdrawal. The …
Cipralex shows fewer side-effects than Efexor
October 25, 2004Lundbeck says two new studies prove that patients taking its antidepressant Cipralex (escitalopram) gain relief faster and suffer fewer side-effects …
Equality champion to tackle NHS diversity agenda
October 21, 2004The NHS has engaged its first equality and human rights director to head up its diversity agenda. Surinder Sharma has …
Abbott third quarter profits grow as Humira sales soar
October 21, 2004Abbott Laboratories' third quarter profits grew by 8.7% to $853 million, driven by global sales increases of 10.2%, which were …
Buoyant Roche to enter cholesterol market
October 21, 2004Roche has announced an alliance with a Japanese company to develop and market JTT-705 a promising new treatment for cholesterol.The …
Immunisation factfile launched to promote 5-in-1 jab
October 13, 2004France, MMR, public health, vaccines
Aventis Pasteur MSD has collaborated with public health bodies in producing a Factfile in support of the company’s new 5-in-1 …
RSA launches consultancy division
October 13, 2004Recruitment services company RSA has launched a new division to offer specialised consulting services to the pharma and biotech industries. …
Climbing the knowledge pyramid
October 11, 2004Product and marketing management are key roles in a brand-led pharma business. The majority of post holders come from within …
